FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2412260950> ?p ?o ?g. }

• W2412260950 endingPage "40" @default.
• W2412260950 startingPage "18434" @default.
• W2412260950 abstract "Glioblastoma (GBM) is the most common brain tumor with high abilities of proliferation, migration and invasion. As is well-known, the peritumoral excitotoxic neuronal cell loss caused by glutamate, secreted by GBM cells, through activated N-methyl-D aspartate receptor (NMDAR) of neuronal cell. What's more, glutamate benefits the migration of GBM cells. However, the glutamate will not kill the GBM cells itself, which may be due to the deficiency of NMDAR. Fasudil, a ROCK inhibitor, was applied for subarachnoid hemorrhage (SAH) in clinic for many years. And it was found to be of potential to inhibit the proliferation, migration and invasion of GBM cells. In present study, we applied fasudil on the primary human GBM cells to further investigate the reduction of cell viability combined with glutamate. Combination treatment of glutamate and fasudil could significantly decrease the cell viability and elevate the level of LDH compared with fasudil treatment alone. What's more, MK-801, a NMDAR antagonist, could partially abolish this death caused by combination treatment. Further study found that the expression level of NMDAR-2B was elevated after treatment with fasudil in GBM cells. These results demonstrated fasudil could increase the expression level of NMDAR, which is necessary for glutamate to work. In a word, our research has provided a new sight of medicine combination in the treatment of GBM." @default.
• W2412260950 created "2016-06-24" @default.
• W2412260950 creator A5009546276 @default.
• W2412260950 creator A5017417512 @default.
• W2412260950 creator A5021229710 @default.
• W2412260950 creator A5027592431 @default.
• W2412260950 creator A5049046565 @default.
• W2412260950 creator A5061101217 @default.
• W2412260950 creator A5070825762 @default.
• W2412260950 creator A5089104513 @default.
• W2412260950 date "2015-01-01" @default.
• W2412260950 modified "2023-09-26" @default.
• W2412260950 title "Combined treatment of fasudil and glutamate decreased the viability of human glioblastoma cells by excitotoxicity through NMDAR in vitro." @default.
• W2412260950 cites W1972363153 @default.
• W2412260950 cites W1975057223 @default.
• W2412260950 cites W1980081948 @default.
• W2412260950 cites W1980311878 @default.
• W2412260950 cites W1983011025 @default.
• W2412260950 cites W1984975372 @default.
• W2412260950 cites W1988198142 @default.
• W2412260950 cites W1992019104 @default.
• W2412260950 cites W1997855586 @default.
• W2412260950 cites W1998319940 @default.
• W2412260950 cites W1999236394 @default.
• W2412260950 cites W2019061150 @default.
• W2412260950 cites W2023903628 @default.
• W2412260950 cites W2030950431 @default.
• W2412260950 cites W2036625562 @default.
• W2412260950 cites W2043520273 @default.
• W2412260950 cites W2044763315 @default.
• W2412260950 cites W2052110007 @default.
• W2412260950 cites W2059944523 @default.
• W2412260950 cites W2060099604 @default.
• W2412260950 cites W2064561511 @default.
• W2412260950 cites W2073678040 @default.
• W2412260950 cites W2138420561 @default.
• W2412260950 cites W2160648225 @default.
• W2412260950 cites W2164773621 @default.
• W2412260950 cites W2168809780 @default.
• W2412260950 cites W2460618565 @default.
• W2412260950 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4694349" @default.
• W2412260950 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26770449" @default.
• W2412260950 hasPublicationYear "2015" @default.
• W2412260950 type Work @default.
• W2412260950 sameAs 2412260950 @default.
• W2412260950 citedByCount "1" @default.
• W2412260950 countsByYear W24122609502022 @default.
• W2412260950 crossrefType "journal-article" @default.
• W2412260950 hasAuthorship W2412260950A5009546276 @default.
• W2412260950 hasAuthorship W2412260950A5017417512 @default.
• W2412260950 hasAuthorship W2412260950A5021229710 @default.
• W2412260950 hasAuthorship W2412260950A5027592431 @default.
• W2412260950 hasAuthorship W2412260950A5049046565 @default.
• W2412260950 hasAuthorship W2412260950A5061101217 @default.
• W2412260950 hasAuthorship W2412260950A5070825762 @default.
• W2412260950 hasAuthorship W2412260950A5089104513 @default.
• W2412260950 hasConcept C126322002 @default.
• W2412260950 hasConcept C1491633281 @default.
• W2412260950 hasConcept C170493617 @default.
• W2412260950 hasConcept C201800478 @default.
• W2412260950 hasConcept C2776048814 @default.
• W2412260950 hasConcept C2781012912 @default.
• W2412260950 hasConcept C502942594 @default.
• W2412260950 hasConcept C53227056 @default.
• W2412260950 hasConcept C55493867 @default.
• W2412260950 hasConcept C61174792 @default.
• W2412260950 hasConcept C62478195 @default.
• W2412260950 hasConcept C67018056 @default.
• W2412260950 hasConcept C71924100 @default.
• W2412260950 hasConcept C86803240 @default.
• W2412260950 hasConcept C95444343 @default.
• W2412260950 hasConcept C98274493 @default.
• W2412260950 hasConceptScore W2412260950C126322002 @default.
• W2412260950 hasConceptScore W2412260950C1491633281 @default.
• W2412260950 hasConceptScore W2412260950C170493617 @default.
• W2412260950 hasConceptScore W2412260950C201800478 @default.
• W2412260950 hasConceptScore W2412260950C2776048814 @default.
• W2412260950 hasConceptScore W2412260950C2781012912 @default.
• W2412260950 hasConceptScore W2412260950C502942594 @default.
• W2412260950 hasConceptScore W2412260950C53227056 @default.
• W2412260950 hasConceptScore W2412260950C55493867 @default.
• W2412260950 hasConceptScore W2412260950C61174792 @default.
• W2412260950 hasConceptScore W2412260950C62478195 @default.
• W2412260950 hasConceptScore W2412260950C67018056 @default.
• W2412260950 hasConceptScore W2412260950C71924100 @default.
• W2412260950 hasConceptScore W2412260950C86803240 @default.
• W2412260950 hasConceptScore W2412260950C95444343 @default.
• W2412260950 hasConceptScore W2412260950C98274493 @default.
• W2412260950 hasIssue "10" @default.
• W2412260950 hasLocation W24122609501 @default.
• W2412260950 hasOpenAccess W2412260950 @default.
• W2412260950 hasPrimaryLocation W24122609501 @default.
• W2412260950 hasRelatedWork W1994997357 @default.
• W2412260950 hasRelatedWork W1999197073 @default.
• W2412260950 hasRelatedWork W2026412974 @default.
• W2412260950 hasRelatedWork W2041098374 @default.
• W2412260950 hasRelatedWork W2047632293 @default.
• W2412260950 hasRelatedWork W2149986334 @default.

• next